Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
Abstract
Correction to: J Pharm Policy Pract (2020) 13:18
https://doi.org/10.1186/s40545-020-00219-1
Following publication of the original article [1], we
notified of a mistake in the article’s title.
Correct article title:
Amid COVID-19: the importance of developing a
positive reporting culture of adverse drug reaction
(ADR) and medical device incident (MDI) for Global
Health and public safety